Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
As a part of Takeda, BioLife values all donors and does not discriminate based on any characteristic protected by Federal, state or local law
Tirzepatide (Mounjaro) Tirzepatide is a medication that contains both a GLP-1 analogue and another incretin called Gastric inhibitory peptide (GIP), which has many of the same actions as GLP-1, so the two work together
The cardiac benefits of GLP-1 agonists were not anticipated before outcome studies were performed for several reasons: (1) Historical Precedent-past experiences with other diabetes medications that unexpectedly had adverse cardiovascular effects made it less likely for researchers and clinicians to anticipate potential cardiovascular benefits without concrete evidence from large-scale trials
So overall, they're not as safe
Understanding the differences helps you make an informed choice during your consultation
US$ 21.54
US$ 26.83
US$ 28.10
US$ 20.02
US$ 20.11
US$ 21.09
US$ 20.69
US$ 22.62
US$ 22.91
US$ 28.88
US$ 21.15
